Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Back to Intelligence
Breaking
PepsiCo recalls 122,021 Gatorade cases; UAE pharmacies should check parallel imports

PepsiCo recalls 122,021 Gatorade cases; UAE pharmacies should check parallel imports

PepsiCo’s US Gatorade recall is a stock-control test for UAE clinics, insurers and pharmacies. Operators should check imported bottles and advise dye-sensitive patients.

Zavis Intelligence·Healthcare Industry Desk
7 Oct 2026·3 min read

How Zavis verifies this coverage

Editorial standards, source rules, methodology, and review provenance are public.

PepsiCo has recalled 122,021 cases of selected 28-ounce Gatorade bottles in the US after undeclared Yellow No. 5 and/or Yellow No. 6 appeared on products sold without the dyes listed on labels, according to the Patch report and the US Food and Drug Administration enforcement record.

For UAE healthcare operators, the immediate risk is limited but practical. Dubai clinics, pharmacies and sports-medicine providers should ask suppliers to confirm whether any US-labelled 28-ounce stock entered the UAE through parallel import channels. The highest-stakes readers are COOs, pharmacy directors and insurers, because the issue is inventory control, patient triage and avoidable claims.

What was recalled

The recall covers Gatorade Lemon Lime, Gatorade Lemon Lime Zero, Gatorade Orange and Gatorade Orange Zero in 28-ounce bottles. The FDA classified the action as Class II on 2 October 2026, after PepsiCo initiated the recall on 25 September 2026. The affected lot and date codes include products dated between April 2027, May 2027 and June 2027, according to recall summaries citing the FDA enforcement report.

“Class II” means product exposure may cause temporary or medically reversible adverse health consequences, according to the US Food and Drug Administration.

The recall was reported in Alabama and other US states. The public reports reviewed for this article do not identify the UAE as an affected market. That distinction matters. UAE pharmacies should treat this as a verification exercise, not a domestic recall, unless a local authority or distributor issues a UAE notice.

Why Dubai operators should care

Sports drinks are sold through supermarkets, gyms, delivery apps and pharmacies in the UAE. Carrefour UAE listed 495ml Gatorade bottles at AED 4.99 in recent online listings, while Noon listed single 495ml bottles at about AED 5.95 and 12-packs at about AED 50.25 to AED 68.50, depending on flavour and seller. Those prices give pharmacy teams a simple exposure test: the financial value of removing a small number of suspect bottles is lower than the cost of one complaint, refund dispute or avoidable consultation.

Dubai food safety sits with Dubai Municipality and the federal food-control framework led by the Ministry of Climate Change and Environment. Healthcare operations still touch three health regulators: the Dubai Health Authority (DHA) for Dubai pharmacies and clinics, the Department of Health Abu Dhabi (DOH) for Abu Dhabi and Al Ain, and the Ministry of Health and Prevention (MOHAP) for the northern emirates. If a patient reports a reaction after buying a product from a pharmacy, the pharmacy record, complaint log and supplier invoice become healthcare governance documents.

  • Ask distributors within 24 to 48 hours whether any US 28-ounce Gatorade stock was supplied.
  • Check bottle size, flavour, lot code and best-before date against the FDA-linked recall summaries.
  • Separate suspect stock pending supplier confirmation and document the action in the pharmacy log.
  • Tell dye-sensitive patients to bring the bottle, receipt and any symptoms to a licensed clinician or pharmacist.

What insurers and clinics should do

For insurers such as Daman, Thiqa and Sukoon, the likely claims impact is small unless UAE distribution is confirmed. The operational step is to brief call-centre and pre-authorisation teams. A patient with rash, wheeze, vomiting or other acute symptoms should follow the normal urgent-care pathway under the policy terms. A patient asking for reimbursement for discarded drinks should be routed to the retailer or distributor.

Medical directors should keep the clinical message narrow. Yellow No. 5 and Yellow No. 6 are permitted colour additives in some markets, but undeclared ingredients matter for patients with known sensitivity, parents managing children’s diets and consumers tracking additives for medical reasons. Clinicians should record the brand, bottle size, batch details and time of consumption before attributing symptoms to the product.

UAE patients should first check whether their bottle is a US-labelled 28-ounce product in one of the four affected flavours. Most UAE retail listings seen for this article were 495ml bottles. Patients who need a pharmacist, or operators checking licensed pharmacy providers, can use the UAE Open Healthcare Directory, which lists licensed providers across Dubai, Abu Dhabi, Al Ain and the northern emirates.

ZI

Zavis Intelligence

Healthcare Industry Desk

Contributing to UAE healthcare industry coverage

Source: Patch

FAQ

What is happening in UAE healthcare industry?

PepsiCo’s US Gatorade recall is a stock-control test for UAE clinics, insurers and pharmacies. Operators should check imported bottles and advise dye-sensitive patients.